Pfizer ( PFE ) posted what looked like a good quarter – at first glance anyway – as key drugs posted strong sales growth. So why has the pharmaceutical giant’s share price dropped more than 2.4% in recent market action? Perhaps it’s the questions that still loom regarding when or if the company will split into two.